Clinical and pathologic aspects of basal-like breast cancers.
about
The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisMembrane progesterone receptor alpha as a potential prognostic biomarker for breast cancer survival: a retrospective studyAnalysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factorsLack of evidence for KRAS oncogenic mutations in triple-negative breast cancer.CrkII transgene induces atypical mammary gland development and tumorigenesis.Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEKWnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome.Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancerLapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts.Clinicopathlogic and immunohistochemical characteristics of triple negative invasive lobular carcinoma.TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer.Role of ERRF, a novel ER-related nuclear factor, in the growth control of ER-positive human breast cancer cellsPhospho-specific Smad3 signaling: impact on breast oncogenesis.Inhibition of CDK-mediated phosphorylation of Smad3 results in decreased oncogenesis in triple negative breast cancer cells.Basal-like breast cancer: molecular profiles, clinical features and survival outcomesSystemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.A rare case of extensive ductal carcinoma in situ of the breast with secretory featuresInsights into endometrial serous carcinogenesis and progression.Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells.CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts.Synthesis, Crystal Study, and Anti-Proliferative Activity of Some 2-Benzimidazolylthioacetophenones towards Triple-Negative Breast Cancer MDA-MB-468 Cells as Apoptosis-Inducing Agents.Integrated analysis of genome-wide DNA methylation and gene expression profiles in molecular subtypes of breast cancerBiomarkers for Basal-like Breast Cancer.Arsenic-induced cancer cell phenotype in human breast epithelia is estrogen receptor-independent but involves aromatase activation.MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer.Correlation between gene expression profiling-based molecular and morphologic classification of breast cancer.Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature.Inflammation fuels tumor progress and metastasis.Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohortGene expression in local stroma reflects breast tumor states and predicts patient outcome.Stemming the tide of cancer for BRCA1/2 mutation carriers.Stabilization of the transcription factors slug and twist by the deubiquitinase dub3 is a key requirement for tumor metastasis.Breast cancer subtypes: morphologic and biologic characterization.Pattern-based sensing of triple negative breast cancer cells with dual-ligand cofunctionalized gold nanoclusters.Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.
P2860
Q28388257-CBF747DA-6669-46B5-976C-D2FF71C98EB1Q28730745-5D363C8A-AC10-430E-8BC8-4026AD42B466Q33483633-8BC3FCD5-10C9-4A88-8C0D-A979C3763A9BQ33552870-DBF35142-8433-4F4C-9628-FE024CD07960Q33556409-BA3B18CA-2D7D-44C7-BCBB-3302F1003621Q33562476-8D15957F-6B11-4A9C-8061-C8965CC2F82FQ33882525-9F6FB16E-2DA2-4F41-9F57-AE4BC64F2D13Q33986198-9966DD22-AD8B-4259-9C8F-B3ECB078B670Q34291564-F2088C72-2D41-4312-B586-995AA970AE2DQ34474679-B223D03B-C9F5-4305-A516-DA49D0B90C3DQ34735167-5F57E22D-1BA1-4914-944C-FE76C7786F97Q35952045-DE775D27-3E71-406F-B083-E3066C50348AQ36116217-742477CF-66C1-4544-8C3F-77672ACCED76Q36187896-8C8926EA-6682-4327-A2B3-40F200300C58Q36325873-1D5A4DD8-768F-4652-AB18-83D5818D11AEQ36490744-03B94B35-1810-4AA7-A263-BA96A766AA32Q36569351-798398BB-3975-49E3-AED6-81BE3C3B300FQ37127024-6CBCF5DF-060B-417F-87DA-95250DFFF391Q37131339-F5086A6D-2998-49FA-917A-81B7CBD60FCDQ37141981-171CCE8B-3AC2-4140-9DE2-7F7F1FD9159CQ37209905-70BF8E6F-D5B4-487E-A43B-50E4CC70AF7FQ37224735-89C68246-97ED-4988-9176-ABE6E07789E8Q37328394-45BBAB25-0965-469B-BE64-6CF252EFC5B5Q37624860-527C21BE-728D-412A-85FF-55342EEE8A4FQ37733747-BA1379EC-B643-41CB-ABD3-58C505A11696Q37756398-F624E3A6-B800-4273-A92F-A02537B81D80Q37967029-E818275A-2E84-4118-93C9-F1A6E0ED85BAQ38500455-2AE93F92-5B1B-4A43-8545-4A255843F1E7Q38692982-E2A6C2F2-A5AC-40A5-97B1-AB7659A95A3CQ41130064-D8DA8B56-CE04-41B3-B60F-D8819C76FB38Q42351561-15287A5A-8F1B-44AD-9CB6-7BE7D826C6FFQ43197215-B9005182-0446-4705-B625-90A7431E4931Q47108833-476706EF-D835-4FD1-993C-F1618BF93B34Q49320962-2A9F1E40-783B-45D6-BCFB-CCE556572554Q49754519-B9DDB50D-E02A-45F7-815F-95F60DE25ABAQ51531354-C3A87B2C-08D0-4DCC-BD95-1E4EC971C537
P2860
Clinical and pathologic aspects of basal-like breast cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical and pathologic aspects of basal-like breast cancers.
@en
Clinical and pathologic aspects of basal-like breast cancers.
@nl
type
label
Clinical and pathologic aspects of basal-like breast cancers.
@en
Clinical and pathologic aspects of basal-like breast cancers.
@nl
prefLabel
Clinical and pathologic aspects of basal-like breast cancers.
@en
Clinical and pathologic aspects of basal-like breast cancers.
@nl
P2860
P356
P1476
Clinical and pathologic aspects of basal-like breast cancers.
@en
P2093
Fattaneh A Tavassoli
Oluwole Fadare
P2860
P304
P356
10.1038/NCPONC1038
P577
2008-03-01T00:00:00Z